THUWAL.- Time is running out, say researchers who are proposing a framework to guide the safe use of microbes to restore global biodiversity loss.

"Anthropogenic impacts have been causing the rapid decline of key ecosystems that are central to supporting our livelihoods," warns KAUST marine scientist Raquel Peixoto.

"Restoring beneficial bacteria provides an emerging tool to improve wildlife health and resilience," she says. "If successful, this option could reboot healthy microbiomes and protect key and sensitive symbiotic relationships between hosts and their associated microbes."

Although the application of "probiotics" has proven beneficial for treating some human, crop and aquaculture diseases, their wider use within ecosystems and wildlife has not been extensively explored. Regulations vary worldwide on how to assess probiotic safety and conversations are needed around the ethics of their more widespread use.

Peixoto is the founder and co-chair of the Beneficial Microbes for Marine Organisms (BMMO) network, which held a roundtable discussion on this topic at the 15th Symposium on Bacterial Genetics and Ecology in Lisbon, Portugal, in 2019.




The roundtable emphasized the urgency for developing a framework that clearly evaluates the need for microbiome stewardship: the monitoring and restoration of microbes associated with organisms and ecosystems towards a healthy, rather than a pathogenic, state. Together, an international team of leading experts in microbial ecology, microbiome manipulation, environmental management and bioethics discussed, evaluated and brainstormed to design a science-based and flexible framework that could help accelerate responsible research and development of microbiome stewardship.

The recently published framework outlines steps that could ultimately be taken to administer probiotics to wildlife.

The first step involves conducting initial assessments of the problem that needs to be addressed, including understanding the biology of the targeted species, examining existing alternative treatments and weighing the risks of inaction against the benefits of taking action.

Next, appropriate probiotic strains are chosen. Known pathogenic strains must be excluded while the use of native, abundant symbiotic species should be prioritized.

The effective dosage and delivery system needs to be determined, with factors considered such as shelf life, storage, handling and dispersion when applied to surfaces.

Finally, probiotic application should be recommended for full in-field assessment if the benefits for the target organism are deemed to be greater than the risks to nontarget organisms or the environment.

These steps should be taken using a case-by-case approach. "Our science-based framework provides a pragmatic regulatory environment-adapted tool to guide scientists and stakeholders through the fight against biodiversity loss, taking into consideration the potential side effects of its application, but also considering the high toll of inaction," says Peixoto.